Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 12-1999 | 12-1998 | 12-1997 | 12-1996 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 148,410 | 117,830 | 0 | 0 | 0 |
| Other Working Capital | -114,220 | -52,550 | 0 | 0 | 0 |
| Other Operating Activity | 131,430 | 88,320 | 70,210 | 0 | 0 |
| Operating Cash Flow | $165,620 | $153,600 | $70,210 | $0 | $0 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63,150 | -63,330 | 0 | 0 | 0 |
| Net Acquisitions | -8,000 | -220,730 | 0 | 0 | 0 |
| Other Investing Activity | -13,150 | 13,640 | -130,610 | 0 | 0 |
| Investing Cash Flow | $-84,300 | $-270,420 | $-130,610 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -27,640 | -17,770 | 0 | 0 | 0 |
| Other Financing Activity | 293,340 | 169,250 | 55,160 | 0 | 0 |
| Financing Cash Flow | $265,700 | $151,480 | $55,160 | $0 | $0 |
| Exchange Rate Effect | -3,570 | -4,560 | 1,370 | 0 | 0 |
| Beginning Cash Position | 77,170 | 47,070 | 50,940 | 0 | 0 |
| End Cash Position | 420,030 | 77,170 | 47,070 | 0 | 0 |
| Net Cash Flow | $342,850 | $30,100 | $-3,860 | $0 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | 165,620 | 153,600 | 70,210 | 0 | 0 |
| Free Cash Flow | 165,620 | 153,600 | 70,210 | 0 | 0 |